HSR22-124: Real-World Outcomes among Patients with Stage IV Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors Versus Immunotherapy with or Without Chemotherapy in First-line Setting
Journal of the National Comprehensive Cancer Network（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined